Skip to main content

Advertisement

Table 3 Predose and average postdose PERMP scores: PERMP total, PERMP-A, and PERMP-C (n = 104)

From: Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

  Predose PERMP Mean (SD) Average Postdose PERMP Mean (SD) Difference in Postdose LS Mean (95% CI) (LDX/Placebo) P Value
PERMP total
   While receiving LDX 260.1 (86.23) 312.7 (94.42) 23.4 (15.6, 31.2) < .0001
   While receiving placebo 261.4 (74.96) 287.6 (81.45)   
PERMP-A
   While receiving LDX 132.2 (43.28) 158.4 (47.53) 12.0 (8.1, 15.8) < .0001
   While receiving placebo 132.6 (37.62) 145.7 (41.06)   
PERMP-C
   While receiving LDX 127.9 (43.02) 154.3 (46.96) 11.5 (7.6, 15.4) < .0001
   While receiving placebo 128.8 (37.39) 141.9 (40.44)   
  1. CI = confidence interval; LDX = lisdexamfetamine dimesylate; LS = least squares; PERMP = Permanent Product Measure of Performance; PERMP-A = PERMP-Attempted; PERMP-C = PERMP-Correct.